MARKET

PFE

PFE

Pfizer
NYSE
27.41
-0.39
-1.40%
After Hours: 27.43 +0.02 +0.07% 19:59 10/05 EDT
OPEN
27.65
PREV CLOSE
27.80
HIGH
27.72
LOW
27.12
VOLUME
33.01M
TURNOVER
--
52 WEEK HIGH
29.21
52 WEEK LOW
22.57
MARKET CAP
156.23B
P/E (TTM)
36.29
1D
5D
1M
3M
1Y
5Y
1D
Pfizer (PFE) Reports Positive Phase 3 Vitiligo Results And Eyes Global Filings
Simply Wall St · 7h ago
Bristol Myers Squibb Co. Stock Sheds 3.8%, Underperforms Peers
Dow Jones · 11h ago
Novavax Inc. Stock Rises 20.1%, Outperforms Peers
Dow Jones · 11h ago
Why Pfizer Might Be the Most Underrated Dividend Stock to Buy Right Now
The Motley Fool · 12h ago
Florida Attorney General Sues Pfizer for 'Misleading' COVID-19 Vaccine Safety Claims
Benzinga · 13h ago
BioTech TRex Bio Set to Roar Onto Nasdaq With $133M IPO
TipRanks · 15h ago
Vaxcyte jumps on phase 3 data for pneumonia vaccine VAX-31
Seeking Alpha · 17h ago
Vaxcyte Stock Spikes 57% as Lead Vaccine Candidate Takes Aim at Pfizer and Merck
Barron‘s · 17h ago
More
About PFE
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, and others. Its PF-08653944 is an ultra-long-acting fully biased GLP-1 receptor agonist.

Webull offers Pfizer Inc stock information, including NYSE: PFE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PFE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PFE stock methods without spending real money on the virtual paper trading platform.